Jessica Tassan
Stock Analyst at Piper Sandler
(1.23)
# 3,349
Out of 4,793 analysts
69
Total ratings
32.14%
Success rate
-10.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Overweight | $72 → $74 | $63.66 | +16.24% | 5 | Mar 21, 2025 | |
| CTEV Claritev | Maintains: Neutral | $10 → $19 | $20.01 | -5.05% | 1 | Mar 10, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $14 → $21 | $18.11 | +15.96% | 5 | Mar 4, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $13 → $12 | $7.29 | +64.61% | 6 | Feb 27, 2025 | |
| EVH Evolent Health | Reiterates: Overweight | $17 → $16 | $9.99 | +60.16% | 3 | Feb 21, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $12 → $8 | $4.01 | +99.50% | 11 | Feb 11, 2025 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $19.44 | -2.26% | 5 | Feb 5, 2025 | |
| CI The Cigna Group | Reiterates: Overweight | $394 → $348 | $322.40 | +7.94% | 3 | Feb 3, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $31 → $33 | $24.31 | +35.75% | 5 | Jan 29, 2025 | |
| HUM Humana | Maintains: Neutral | $270 → $288 | $253.77 | +13.49% | 3 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $605 → $600 | $525.05 | +14.27% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $13.00 | +115.38% | 4 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $15 | $7.03 | +113.37% | 4 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $51.24 | -55.11% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $32.69 | +114.13% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $6.59 | +962.22% | 2 | Feb 27, 2023 |
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $63.66
Upside: +16.24%
Claritev
Mar 10, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $20.01
Upside: -5.05%
Alignment Healthcare
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $18.11
Upside: +15.96%
Teladoc Health
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.29
Upside: +64.61%
Evolent Health
Feb 21, 2025
Reiterates: Overweight
Price Target: $17 → $16
Current: $9.99
Upside: +60.16%
Health Catalyst
Feb 11, 2025
Maintains: Overweight
Price Target: $12 → $8
Current: $4.01
Upside: +99.50%
Premier
Feb 5, 2025
Maintains: Neutral
Price Target: $21 → $19
Current: $19.44
Upside: -2.26%
The Cigna Group
Feb 3, 2025
Reiterates: Overweight
Price Target: $394 → $348
Current: $322.40
Upside: +7.94%
Phreesia
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $24.31
Upside: +35.75%
Humana
Jan 15, 2025
Maintains: Neutral
Price Target: $270 → $288
Current: $253.77
Upside: +13.49%
Jan 2, 2025
Maintains: Overweight
Price Target: $605 → $600
Current: $525.05
Upside: +14.27%
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $13.00
Upside: +115.38%
Jan 9, 2024
Maintains: Overweight
Price Target: $12 → $15
Current: $7.03
Upside: +113.37%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $51.24
Upside: -55.11%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $32.69
Upside: +114.13%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $6.59
Upside: +962.22%